Pictet Asset Management’s NewAmsterdam Pharma NAMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.9M | Buy |
1,816,725
+4,776
| +0.3% | +$86.5K | 0.03% | 396 |
|
|
2025
Q1 | $37.1M | Buy |
1,811,949
+654,497
| +57% | +$13.4M | 0.04% | 361 |
|
|
2024
Q4 | $29.7M | Buy |
1,157,452
+140,605
| +14% | +$3.61M | 0.03% | 396 |
|
|
2024
Q3 | $16.9M | Buy |
1,016,847
+333,166
| +49% | +$5.53M | 0.02% | 535 |
|
|
2024
Q2 | $13.1M | Buy |
683,681
+33,945
| +5% | +$652K | 0.02% | 578 |
|
|
2024
Q1 | $15.4M | Buy |
+649,736
| New | +$15.4M | 0.02% | 562 |
|